Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.

Moffett BS, Jefferies JL, Price JF, Clunie S, Denfield S, Dreyer WJ, Towbin JA.

Pharmacotherapy. 2006 Feb;26(2):277-80.

PMID:
16466333
2.

Nesiritide in infants and children with congestive heart failure.

Mahle WT, Cuadrado AR, Kirshbom PM, Kanter KR, Simsic JM.

Pediatr Crit Care Med. 2005 Sep;6(5):543-6.

PMID:
16148814
3.

A prospective evaluation of nesiritide in the treatment of pediatric heart failure.

Jefferies JL, Denfield SW, Price JF, Dreyer WJ, McMahon CJ, Grenier MA, Kim JJ, Dimas VV, Clunie SK, Moffett BS, Chang AC, Wann TI, Smith EO, Towbin JA.

Pediatr Cardiol. 2006 Jul-Aug;27(4):402-7.

PMID:
16830089
4.

Safety and efficacy of nesiritide in pediatric heart failure.

Jefferies JL, Price JF, Denfield SW, Chang AC, Dreyer WJ, McMahon CJ, Grenier MA, Clunie SK, Thomas A, Moffett BS, Wann TS, Smith EO, Towbin JA.

J Card Fail. 2007 Sep;13(7):541-8.

PMID:
17826644
5.

Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

Peacock WF 4th, Holland R, Gyarmathy R, Dunbar L, Klapholz M, Horton DP, de Lissovoy G, Emerman CL.

J Emerg Med. 2005 Oct;29(3):243-52.

PMID:
16183441
6.

Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.

Hiestand B, Abraham WT.

Curr Cardiol Rep. 2007 May;9(3):182-6. Review.

PMID:
17470330
7.

Hemodynamic effects and safety of nesiritide in neonates with heart failure.

Simsic JM, Mahle WT, Cuadrado A, Kirshbom PM, Maher KO.

J Intensive Care Med. 2008 Nov-Dec;23(6):389-95. doi: 10.1177/0885066608324296. Epub 2008 Sep 19.

PMID:
18805856
8.

Efficacy and safety of nesiritide in patients with acute decompensated heart failure.

DeWald TA, Hernandez AF.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):159-69. doi: 10.1586/erc.09.173. Review.

PMID:
20136602
9.

Nesiritide: harmful or harmless?

Dorsch MP, Rodgers JE.

Pharmacotherapy. 2006 Oct;26(10):1465-78. Review.

PMID:
16999657
10.

Nesiritide improves hemodynamics in children with dilated cardiomyopathy: a pilot study.

Behera SK, Zuccaro JC, Wetzel GT, Alejos JC.

Pediatr Cardiol. 2009 Jan;30(1):26-34. doi: 10.1007/s00246-008-9272-6. Epub 2008 Aug 15.

PMID:
18704555
12.

Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.

Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.

J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):232-6.

PMID:
17875951
13.

Safety and efficacy of nesiritide for the treatment of decompensated heart failure.

Emerman CL.

Rev Cardiovasc Med. 2002;3 Suppl 4:S28-34. Review.

PMID:
12439428
14.

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.

Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R; FUSION II Investigators.

Circ Heart Fail. 2008 May;1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483.

15.

Nesiritide use in pediatric patients with congestive heart failure.

Feingold B, Law YM.

J Heart Lung Transplant. 2004 Dec;23(12):1455-9.

PMID:
15607680
16.

Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.

Munger MA, Ng TM, Van Tassell BW.

Pharmacotherapy. 2007 May;27(5):619-25. Review.

PMID:
17461695
17.

Nesiritide: trials and tribulations.

Arora RR.

J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):165-9. Review.

PMID:
17056828
18.

Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.

Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.

Circulation. 2004 Sep 21;110(12):1620-5. Epub 2004 Aug 30.

19.

Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.

Abraham WT, Trupp RJ, Jarjoura D.

Clin Cardiol. 2010 Aug;33(8):484-9. doi: 10.1002/clc.20793.

20.

Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.

Abraham WT, Cheng ML, Smoluk G; Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Study Group.

Congest Heart Fail. 2005 Mar-Apr;11(2):59-64.

Supplemental Content

Support Center